Hudson Capital Management LLC increased its holdings in shares of Express Scripts (NASDAQ:ESRX) by 16.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,106 shares of the company’s stock after acquiring an additional 1,866 shares during the period. Hudson Capital Management LLC’s holdings in Express Scripts were worth $905,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of ESRX. Great West Life Assurance Co. Can lifted its stake in shares of Express Scripts by 8.4% in the first quarter. Great West Life Assurance Co. Can now owns 1,577,528 shares of the company’s stock worth $109,065,000 after buying an additional 122,015 shares in the last quarter. Todd Asset Management LLC lifted its stake in shares of Express Scripts by 78.5% in the first quarter. Todd Asset Management LLC now owns 326,984 shares of the company’s stock worth $22,588,000 after buying an additional 143,768 shares in the last quarter. Morningstar Investment Services LLC lifted its stake in shares of Express Scripts by 8.4% in the first quarter. Morningstar Investment Services LLC now owns 449,138 shares of the company’s stock worth $31,026,000 after buying an additional 34,702 shares in the last quarter. CQS Cayman LP bought a new position in shares of Express Scripts in the first quarter worth approximately $518,000. Finally, Natixis Advisors L.P. lifted its stake in shares of Express Scripts by 74.8% in the first quarter. Natixis Advisors L.P. now owns 69,353 shares of the company’s stock worth $4,791,000 after buying an additional 29,676 shares in the last quarter. 85.82% of the stock is currently owned by institutional investors and hedge funds.
In other Express Scripts news, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total transaction of $368,397.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christine Houston sold 19,889 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by insiders.
ESRX has been the topic of several analyst reports. Sanford C. Bernstein downgraded shares of Express Scripts from a “market perform” rating to an “underperform” rating and upped their target price for the stock from $55.80 to $77.50 in a research note on Tuesday, January 30th. Royal Bank of Canada upgraded shares of Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 target price on the stock in a research note on Wednesday, January 31st. BidaskClub downgraded shares of Express Scripts from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a research note on Wednesday, February 14th. Finally, Maxim Group reiterated a “buy” rating and issued a $87.00 target price on shares of Express Scripts in a research note on Monday, February 26th. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $82.50.
Express Scripts opened at $77.08 on Friday, according to MarketBeat.com. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.69 and a quick ratio of 0.56. Express Scripts has a twelve month low of $55.80 and a twelve month high of $85.07. The company has a market cap of $43.14 billion, a PE ratio of 10.86, a P/E/G ratio of 0.97 and a beta of 0.98.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Wednesday, May 2nd. The company reported $1.77 earnings per share for the quarter, beating the consensus estimate of $1.76 by $0.01. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The firm had revenue of $24.77 billion during the quarter, compared to analysts’ expectations of $24.80 billion. During the same period in the previous year, the company earned $1.33 earnings per share. The firm’s quarterly revenue was up .5% on a year-over-year basis. research analysts predict that Express Scripts will post 9.07 EPS for the current fiscal year.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.